2024 ICD-10-CM Diagnosis Code L80

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• Achalasia of esophagus
• Complete deafness
• Congenital achalasia of esophagus
• Congenital deafness
• Deafness, vitiligo, achalasia syndrome
• Generalized vitiligo
• Idiopathic vitiligo
• Localized vitiligo
• Mucosal vitiligo
• Occupational vitiligo
• Segmental vitiligo
• Trichrome vitiligo
• Vitiligo
• Vitiligo due to Köbnerization

Clinical Information

• Vitiligo

  a disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.

• FACIT-Searchable Item Library Adult Version - Bothered by Vitiligo|FSIL-Bothered by Vitiligo|FSIL-Bothered by Vitiligo|FSIL0419

  functional assessment of chronic illness therapy-searchable item library adult version (facit-searchable item library adult version) i am bothered by vitiligo (white patches appearing on my skin).

• F-Box Only Protein 11|FBXO11|Protein Arginine N-Methyltransferase 9|Ubiquitin Protein Ligase E3 Component N-Recognin 6|VIT-1|Vitiligo-Associated Protein 1

  f-box only protein 11 (927 aa, ~104 kda) is encoded by the human fbxo11 gene. this protein plays a role in substrate recognition for the ubiquitin ligase complex.

• Halo Nevus|Halo nevus|Leukoderma Acquisitum Centrifugum|Perinevoid Leukoderma|Perinevoid Vitiligo|Sutton Nevus

  a melanocytic nevus characterized by circumferential depigmentation. it is usually associated with a brisk lymphocytic infiltrate.

• NLRP1 wt Allele|AIADK|CARD7|CIDED|CLR17.1|DEFCAP|DEFCAP-L/S|DKFZp586O1822|KIAA0926|MSPC|NAC|NALP1|NLR Family Pyrin Domain Containing 1 wt Allele|NLR Family, Pyrin Domain Containing 1 Gene|NLRP1A|NLRP1A, Mouse, Homolog of Gene|PP1044|SLEV1|Systemic Lupus Erythematosus, Vitiligo-Related 1 Gene|VAMAS1

  human nlrp1 wild-type allele is located in the vicinity of 17p13.2 and is approximately 120 kb in length. this allele, which encodes nacht, lrr and pyd domains-containing protein 1, is involved in apoptosis induction. mutations in the gene are associated with vitiligo-associated multiple autoimmune disease susceptibility 1.

• Vitiligo

  generalized well circumscribed patches of leukoderma that are generally distributed over symmetric body locations and is due to autoimmune destruction of melanocytes.

L80 is grouped with Diagnostic Related Groups - MS-DRG Mapping

Diagnostic Related Groups (DRGs) are a classification system used to group together diagnosis codes for the purpose of reimbursement and healthcare management. DRGs are used to standardize the way hospitals and other providers are paid for inpatient services. In this system patients are grouped together based on their principal diagnosis in areas referred to as Major Diagnostic Categories (MDC). Once a patient is assigned a particular diagnostic category, providers receive a predetermined payment rate for the services rendered. This reimbursement rate is often fixed and is meant to cover the cost of care for that patient. Reimbursement is also affected by the relative weight of a diagnostic related group based on the severity of a patient's illness and the associated cost of care during hospitalization.

Diagnostic related groups encourage healthcare providers to focus on quality and efficiency in patient care while managing costs effectively. The diagnosis code is present in the following groups for version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.

MS-DRG	MS-DRG Title	MCD	Relative Weight
606	MINOR SKIN DISORDERS WITH MCC	09	1.5858
607	MINOR SKIN DISORDERS WITHOUT MCC	09	0.8935

The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Convert L80 to ICD-9-CM

• ICD-9-CM Code: 709.01 - Vitiligo

Patient Education

Vitiligo

Vitiligo causes white patches on your skin. It can also affect your eyes, mouth, and nose. It occurs when the cells that give your skin its color are destroyed. No one knows what destroys them. It is more common in people with autoimmune diseases, and it might run in families. It usually starts before age 40.

The white patches are more common where your skin is exposed to the sun. In some cases, the patches spread. Vitiligo can cause your hair to gray early. If you have dark skin, you may lose color inside your mouth.

Using sunscreen will help protect your skin, and cosmetics can cover up the patches. Treatments for vitiligo include medicines, light therapy, and surgery. Not every treatment is right for everyone. Many have side effects. Some take a long time. Some do not always work.

NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

[Learn More in MedlinePlus]

Vitiligo

Vitiligo is a condition that causes patchy loss of skin coloring (pigmentation). In addition, hair on these regions of skin can also lose pigment and appear white. The average age of onset of vitiligo is in the mid-twenties, but it can appear at any age. The size and number of patches varies from person to person. The condition tends to progress over time, with larger areas of the skin losing pigment. However, the patches can remain stable or even improve in some affected individuals. 

Researchers have identified several forms of vitiligo. Generalized vitiligo (also called nonsegmental vitiligo), which is the most common form, involves loss of pigment (depigmentation) in patches of skin all over the body. Depigmentation typically occurs on the face, neck, and scalp, and around body openings such as the mouth and genitals. Sometimes pigment is lost in mucous membranes, such as the lips. Loss of pigmentation is also frequently seen in areas that tend to experience rubbing, impact, or other trauma, such as the hands, arms, and places where bones are close to the skin surface (bony prominences). Another form of the condition, called segmental vitiligo, is associated with smaller patches of depigmented skin that appear on one side of the body in a limited area. This form occurs in about 10 percent of affected individuals.

Vitiligo is generally considered to be an autoimmune disorder. Autoimmune disorders occur when the immune system attacks the body's own tissues and organs. In people with vitiligo the immune system appears to attack the pigment cells (melanocytes) in the skin. About 15 to 25 percent of people with vitiligo are also affected by at least one other autoimmune disorder, particularly autoimmune thyroid disease, rheumatoid arthritis, type 1 diabetes, psoriasis, pernicious anemia, Addison disease, systemic lupus erythematosus, celiac disease, Crohn's disease, or ulcerative colitis.

In the absence of other autoimmune conditions, vitiligo does not affect general health or physical functioning. However, concerns about appearance and ethnic identity are significant issues for many affected individuals.

[Learn More in MedlinePlus]

Vitiligo

Vitiligo is a chronic (long-lasting) disorder that causes areas of skin to lose color.
[Learn More in MedlinePlus]

Code History

• FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
• FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
• FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
• FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.